Pharmaceutical Intermediate Cupric Acetate Monohydrate from Canada
Cupric acetate monohydrate as intermediate for pharmaceutical copper complexes, a chemically defined compound under HTS 2915.29.10.00. Used in synthesis of anti-inflammatory agents.
Duty Rate — Canada → United States
10%
Rate breakdown
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• FDA import alert check for contaminants; GMP certificate if for drug synthesis; small quantities under de minimis for samples